A bioactive peptide mixture was first injected on a high load SEC column (superdex 75)and fractionated. However due to the poor performance of the column, another superdex 75 from the same company was used as a second step to purify the fractions from the first SEC column, in this analysis the bioactivity of the fractions is gone.
what can be the reason for this?